Corvus Pharmaceuticals, Inc. (CRVS)

Trade CRVS now with
3/8/2018 9:07:13 AM Corvus Prices Public Offering Of 7.06 Mln Shares At $8.50 Per Share
2/1/2018 8:39:15 AM Corvus Announces Presentation Of New Data From Preclinical Study Of Novel T-Cell Signaling Pathway Inhibitor
8/2/2017 7:22:57 PM Wedbush Starts Corvus Pharmaceuticals, Inc. (CRVS) At Outperform With $26.00 Price Target